Humogen Serum Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-12-2024
- Paid Up Capital ₹ 0.10 M
as on 08-12-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2016
About Humogen Serum
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ranvir Singh, Priyanka Singh, Abhishek Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100MH2011PTC215856
- Company No.
215856
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Apr 2011
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Humogen Serum?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranvir Singh  | Director | 06-Apr-2011 | Current |
| Priyanka Singh | Director | 06-Apr-2011 | Current |
| Abhishek Singh | Director | 06-Apr-2011 | Current |
| Shantanu Singh | Director | 01-Sep-2012 | Current |
Financial Performance of Humogen Serum.
Enhance accessibility to Humogen Serum's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Humogen Serum?
In 2016, Humogen Serum had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Taj Pharma India LimitedActive 13 years 6 monthsRanvir Singh, Priyanka Singh and 2 more are mutual person
Taj Life Sciences Private LimitedActive 16 years 11 daysRanvir Singh, Priyanka Singh and 2 more are mutual person
Taj Pharmaceuticals LimitedActive 20 years 1 monthRanvir Singh and Abhishek Singh are mutual person
Sankara Nethralaya Private LimitedActive 18 years 11 monthsRanvir Singh, Abhishek Singh and 1 more are mutual person
Taj Institute Of Medical Sciences Private LimitedActive 20 years 5 monthsRanvir Singh, Abhishek Singh and 1 more are mutual person
Arcelor Petroleum LimitedActive 15 years 10 monthsRanvir Singh, Priyanka Singh and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Humogen Serum?
Unlock and access historical data on people associated with Humogen Serum, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Humogen Serum, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Humogen Serum's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
